Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-17

Clinical Trial Update: Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TBAJ876 or bedaquiline, with pretomanid and linezolid, for adults with drug-sensitive pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)
  • Pretomanid (pretomanid)
  • TBAJ876
  • bedaquiline (bedaquiline)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary TB, Pulmonary Tuberculosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING